CD155-Prognostic and Immunotherapeutic Implications Based on Multiple Analyses of Databases Across 33 Human Cancers

por Zhang, Hongpan, Yang, Zhihao, Du, Guobo, Cao, Lu, Tan, BangXian
Publicado 2021

Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell car...

por Ma, Dai-yuan, Tan, Bang-xian, Liu, Mi, Li, Xian-fu, Zhou, Ye-qin, Lu, You
Publicado 2014

Efficacy and safety of apatinib plus docetaxel as the second or above line treatment in advanced nonsquamous NSCLC: A multi center prospective study

por Jiang, Qian, Zhang, Ning-Ling, Ma, Dai-Yuan, Tan, Bang-Xian, Hu, Xin, Fang, Xiang-Dong
Publicado 2019

Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report

por Li, Zhi-Ke, Zhao, Qiang, Li, Ning-Fu, Wen, Jing, Tan, Bang-Xian, Ma, Dai-Yuan, Du, Guo-Bo
Publicado 2022

Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC

por Ren, Yue, Wang, Shan-Bing, Zhou, Lin, Liu, Si-Qiao, Du, Lei-Ya, Li, Ting, Jiang, Mao-Qiong, Lei, Kai-Jian, Tan, Bang-Xian, Jia, Yu-Ming
Publicado 2021

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

por Wang, Xiao-Shan, Bai, Yi-Feng, Verma, Vivek, Yu, Rui-Lian, Tian, Wei, Ao, Rui, Deng, Ying, Zhu, Xue-Qiang, Liu, Hao, Pan, Hai-Xia, Yang, Lan, Bai, Han-Song, Luo, Xing, Guo, Yan, Zhou, Ming-Xiu, Sun, Yue-Mei, Zhang, Zi-Can, Li, Si-Min, Cheng, Xue, Tan, Bang-Xian, Han, Liang-Fu, Liu, Ying-Yi, Zhang, Kai, Zeng, Fan-Xin, Jia, Lin, Hao, Xin-Bao, Wang, You-Yu, Feng, Gang, Xie, Ke, Lu, You, Zeng, Ming
Publicado 2022